Stockreport

MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders [Yahoo! Finance]

MAIA Biotechnology, Inc.  (MAIA) 
PDF Shareholder Letter available in Investor Relations section of MAIA's corporate website. CHICAGO, March 05, 2024 BUSINESS WIRE )--MAIA Biotechnology, Inc., (NYSE Ameri [Read more]